Search results for "blee"

showing 10 items of 263 documents

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anti…

2012

Abstract Effective treatment of venous thromboembolism (VTE) strikes a balance between prevention of recurrence and bleeding complications. The current standard of care is heparin followed by a vitamin K antagonist such as warfarin. However, this option is not without its limitations, as the anticoagulant effect of warfarin is associated with high inter- and intra-patient variability and patients must be regularly monitored to ensure that anticoagulation is within the narrow target therapeutic range. Several novel oral anticoagulant agents are in the advanced stages of development for VTE treatment, some of which are given after an initial period of heparin treatment, in line with current p…

medicine.medical_specialtymedicine.drug_classDeep veinReviewTherapeutic indexRecurrencemedicinecardiovascular diseasesIntensive care medicinebusiness.industryHeparinlcsh:RC633-647.5AnticoagulantBleedingWarfarinAnticoagulantsHeparinlcsh:Diseases of the blood and blood-forming organsHematologyVitamin K antagonistmedicine.diseaseThrombosisPulmonary embolismSurgerymedicine.anatomical_structureVitamin K antagonistsbusinessmedicine.drugVenous thromboembolismThrombosis Journal
researchProduct

Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

2017

medicine.medical_specialtymedicine.drug_classLow molecular weight heparin030204 cardiovascular system & hematologyGastroenterology03 medical and health sciences0302 clinical medicineTinzaparinRecurrenceNeoplasmsInternal medicineHumansMedicineCancer associated thrombosisIn patientbusiness.industryLow molecular weight heparinCancer associated thrombosiBleedingAnticoagulantsCancerHematologyTinzaparinmedicine.diseaseAnticoagulant therapy030220 oncology & carcinogenesisbusiness
researchProduct

Antithrombotic treatment and outcomes of splanchnic vein thrombosis in an international prospective registry: Results of 2-year follow-up

2014

Abstract Background: Little information is available on the long-term clinical outcome of patients with splanchnic vein thrombosis (SVT). We aimed to assess incidence rates of bleeding, recurrence, and mortality in a large prospective cohort of SVT patients after a 2-year follow-up. Methods: Consecutive SVT patients were enrolled in a multicenter international registry, from 2008 to 2012. Information was gathered on baseline characteristics, risk factors and therapeutic strategies. Clinical outcomes (major bleeding; vascular events, defined as venous or arterial thrombosis, and mortality) during follow-up were collected and reviewed by a Central Adjudication Committee. Major bleeding was de…

medicine.medical_specialtymedicine.drug_classliver cirrhosisImmunologyanticoagulant agentBiochemistrymaleInternal medicinedeathMedicinefollow upartery thrombosishumanRisk factorProspective cohort studythrombosisriskregisteranticoagulant therapybusiness.industryhematologyIncidence (epidemiology)pathogenesisAnticoagulantCell Biologymedicine.diseasebleedingThrombosismortalitySurgeryVenous thrombosissocietySplanchnic vein thrombosisvein thrombosisrisk factorsolidincidenceantivitamin KpatientbusinessAmericanFibrinolytic agentneoplasmhospitalizationportal vein
researchProduct

Hysteroscopy and treatment of uterine polyps.

2015

This article summarizes and analyzes the salient topics on the diagnosis and management of endometrial polyps, focusing on the role of the hysteroscopy. Noninvasive investigations such as transvaginal ultrasonography, with or without the use of three-dimensional ultrasonography (3D US) and contrast techniques, remain the mainstay of first-line investigation. Hysteroscopic resection represents the gold standard minimally invasive treatment for endometrial polyps. It is the most effective management and allows histologic assessment, whereas blind biopsy or curettage have low diagnostic accuracy and should not be performed.

medicine.medical_specialtymedicine.medical_treatmentBiopsyAbnormal uterine bleedingHysteroscopyUterine polypsPolypsBiopsymedicineEndometrial PolypAmbulatory CareHumansUltrasonographymedicine.diagnostic_testTransvaginal ultrasonographybusiness.industryObstetrics and GynecologyGeneral MedicineGold standard (test)medicine.diseaseSettore MED/40 - Ginecologia E Ostetriciaabnormal uterine bleeding; endometrial polyps; hysteroscopy; polypectomyPolypectomyCurettageEndometrial NeoplasmsPolypectomyendometrial polypsHysteroscopyFemaleRadiologybusinessEndometrial polypBest practiceresearch. Clinical obstetricsgynaecology
researchProduct

Effect of probiotics as a complement to non-surgical periodontal therapy in chronic periodontitis : a systematic review

2020

Background To improve the results of the classic periodontal treatment, probiotics have been suggested recently to decrease the number of bacteria and the expression of mediators of inflammation. This systematic review aimed to assess the literature for the effectiveness of different probiotic strains as adjuvants to non-surgical periodontal therapy. Material and Methods The electronic database of MEDLINE (via Pubmed) was searched up to December 2017 for randomised clinical trials in English comparing non-surgical periodontal treatment and probiotics versus periodontal treatment and placebo. The primary outcome investigated was reduction in pocket probing depth. Secondary outcomes were blee…

medicine.medical_specialtymedicine.medical_treatmentBleeding on probingDental PlaqueReviewMalalties de la bocaPlaceboDental plaqueMalalties de l'estómac03 medical and health sciences0302 clinical medicineInternal medicinemedicineMucositisHumansPeriodontologyPeriodontitisGeneral DentistryStomatitisbusiness.industryProbioticsDental Plaque Index030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Chronic periodontitisProbiòticsDental Plaque IndexClinical trialMouth diseasesOtorhinolaryngologyDebridement (dental)Chronic PeriodontitisUNESCO::CIENCIAS MÉDICASDental ScalingSurgerymedicine.symptombusinessStomach diseases
researchProduct

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism

2019

Abstract Introduction VTE‐BLEED is a validated score for identification of patients at increased risk of major bleeding during extended anticoagulation for venous thromboembolism (VTE). It is unknown whether VTE‐BLEED high‐risk patients also have an increased risk for recurrent VTE, which would limit the potential usefulness of the score. Methods This was a post hoc analysis of the randomized, double‐blind, placebo‐controlled PADIS‐PE trial that randomized patients with a first unprovoked pulmonary embolism (PE) initially treated during 6 months to receive an additional 18‐month of warfarin vs. placebo. The primary outcome of this analysis was recurrent VTE during 2‐year follow‐up after ant…

medicine.medical_specialtyrecurrencemedicine.drug_classvenous thromboembolismInternal medicinemedicineCumulative incidencecardiovascular diseasesanticoagulation therapylcsh:RC633-647.5business.industryAnticoagulantHazard ratioWarfarinlcsh:Diseases of the blood and blood-forming organsprediction scoreHematologyBleedbleedingequipment and suppliesmedicine.diseaseConfidence intervalPulmonary embolismDiscontinuationOriginal ArticlebusinessOriginal Articles: Thrombosismedicine.drugResearch and Practice in Thrombosis and Haemostasis
researchProduct

Pharmacokinetics of new oral anticoagulants: implications for use in routine care

2018

Introduction: Since 2008, new oral anticoagulants (NOACs) have been approved for the prevention of venous thromboembolism (VTE) in patients receiving hip or knee replacement surgery, prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE). Premarketing randomized clinical trials (RCTs) of NOACs demonstrated their non-inferiority in terms of efficacy vs. warfarin (traditional oral anticoagulant–TOA), with lower risk of serious adverse drug reactions, especially cerebral hemorrhages. In clinical practice, pharmacokinetic aspects of NOACs have to be carefully taken into account to …

medicine.medical_treatmentnew oral anticoagulantsAdministration OralKnee replacement030204 cardiovascular system & hematologyToxicologyAdherence Bleeding Interactions New oral anticoagulants Over- and under-dosage Persistence Pharmacokinetics Real World Evidence0302 clinical medicineAtrial Fibrillationover- and underdosage030212 general & internal medicinepharmacokineticStrokeRoutine careRandomized Controlled Trials as Topicnew oral anticoagulantAtrial fibrillationpersistenceVenous ThromboembolismGeneral MedicinePulmonary embolismStrokepharmacokineticsHumanmusculoskeletal diseasesmedicine.medical_specialtyinteractionHemorrhageMedication Adherence03 medical and health sciencesPharmacokineticsmedicineHumansReal World EvidenceIn patientOver- and under-dosagecardiovascular diseasesreal-world evidenceIntensive care medicineAgedPharmacologybusiness.industryAnticoagulantAnticoagulantsinteractionsbleedingmedicine.diseaseAdherencePulmonary EmbolismbusinessVenous thromboembolismExpert Opinion on Drug Metabolism & Toxicology
researchProduct

Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI

2004

Gradient echo T2*-weighted MRI has high sensitivity in detecting cerebral microbleeds, which appear as small dot-like hypointense lesions. Microbleeds are strongly associated with intracerebral haemorrhage, hypertension, lacunar stroke and ischaemic small vessel disease, and have generated interest as a marker of bleeding-prone microangiopathy. Microbleeds have generally been considered to be clinically silent; however, since they are located in widespread cortical and basal ganglia regions and are histologically characterized by tissue damage, we hypothesized that they would cause cognitive dysfunction. We therefore studied patients with microbleeds (n = 25) and a non-microbleed control gr…

microbleedexecutive functionSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicafrontal lobestrokeMRIcognitive impairment
researchProduct

Periodontal Behavior Around Teeth Prepared with Finishing Line for Restoration with Fixed Prostheses. A Systematic Review and Meta-Analysis

2020

Background: The objective of this systematic review and meta-analysis was to analyze the periodontal behavior around teeth prepared with horizontal finishing crowns supporting fixed metal-ceramic and zirconia full coverage crowns and fixed partial dentures (FDPs). Materials and methods: An electronic search was conducted to locate relevant clinical trials in four databases: PubMed, Embase, Cochrane, and Scopus. A manual search was made in the reference sections of the articles identified for any additional articles. No restrictions were applied regarding year of publication or language. The following variables were considered in quantitative and qualitative analysis: probing pocket depth (P…

periodontal prosthesisBleeding on probingDentistrylcsh:MedicineReviewPlaque controlPeriodontal Prosthesis03 medical and health sciences0302 clinical medicineQualitative analysisstomatognathic systemUntreated controlzirconium oxideMedicinebiological factorbusiness.industryDental prosthesislcsh:Rdental prosthesis030206 dentistryGeneral Medicinestomatognathic diseases030220 oncology & carcinogenesisMeta-analysismedicine.symptombusinessGingival marginmetal ceramic restorationsJournal of Clinical Medicine
researchProduct

Child-Pugh Class and Not Thrombocytopenia Impacts the Risk of Complications of Endoscopic Band Ligation in Patients with Cirrhosis and High Risk Vari…

2023

Background and Aims: Endoscopic band legation (EBL) is an effective method for the prophylaxis of acute variceal bleeding (AVB). This procedure may be associated with several complications, particularly bleeding. Our analysis aimed to evaluate the risk of complications due to EBL in a cohort of patients who underwent EBL for the prophylaxis of variceal bleeding and the eventual presence of risk predictors. Patients and Methods: We retrospectively analysed data from consecutive patients who underwent EBL in a primary prophylaxis regimen. For all patients, simultaneously with EBL, we recorded the Child–Pugh and MELD score, platelet count and US features of portal hypertension. Results: We col…

plateletesophageal band ligation (EBL)clinically significative portal hypertension (CSPH)variceal bleeding (ABV).Medicine (miscellaneous)MELD scorethrombocytopeniaChild–Pugh scorecirrhosi
researchProduct